在接受不同放射治疗方案的乳腺癌患者的染色体损伤
Renu Dayal1, Lama Ramadan1,2, Liv Veldeman2,3,4
1Department of Human Structure and Repair, Radiobiology Lab, Ghent University, Ghent, Belgium.
International journal of radiation biology
|March 9, 2026
概括
与其他方案相比,超低分离放射治疗 (UHF) 可能会减少乳腺癌患者的染色体损伤. 较短的放射治疗计划,每小部分剂量较高,似乎对循环淋巴细胞更安全,可能降低二次癌症风险.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 遗传学 遗传学 是一个
背景情况:
- 放射治疗 (RT) 对乳腺癌 (BC) 治疗至关重要.
- 逆转录可以导致健康组织的染色体损伤,增加二次癌症的风险.
- 调查RT对遗传损伤的影响对于患者安全至关重要.
研究的目的:
- 评估经过不同RT方案的BC患者淋巴细胞中的染色体损伤.
- 评估RT参数对微核 (MN) 产量的影响.
- 为了在初级和第二级BC患者之间比较体外染色体辐射敏感性.
主要方法:
- 细胞动力阻断微核 (CBMN) 试验用于来自182名初级BC患者和50名初级BC患者的淋巴细胞.
- 血液样本采集在RT前和之后,并在体外进行辐射以评估辐射敏感性.
- 统计分析 (线性回归,混合效应模型) 探索了MN产量和RT参数之间的关联.
主要成果:
- 在初级和第二个初级BC患者之间,MN产量没有显著差异.
- 超低分化 (UHF) 方案显示了最低的MN诱导;中度低分化 (MHF-高) 显示了最高的.
- 更高的MN产量与增加的瘤总剂量,更大的辐射体积和淋巴结辐射相关.
结论:
- 较短的RT方案,每小部分剂量较高,可以减少细胞遗传损伤,提高长期安全性.
- 在体外染色体辐射敏感性不是第二次BC风险的可靠指标.
相关概念视频
Mutations
45.0K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
45.0K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
60
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
60
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Other Unique Bacteria
519
Magnetic bacteria exhibit a directed movement called magnetotaxis, driven by structures called magnetosomes. These magnetosomes consist of chains of magnetic particles made of either magnetite (Fe₃O₄) or greigite (Fe₃S₄) and are organized in a linear conformation by a protein scaffold within invaginations of the cell membrane. The bacteria align along the north–south magnetic field lines, much like a compass needle. They are typically microaerophilic or anaerobic...
519


